Akorn Receives Approval for Mycophenolate Mofetil for Injection, USP
Feb 28, 2017 22:30 pm UTC| Business
LAKE FOREST, Ill., Feb. 28, 2017 -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its...
Home BancShares, Inc. to Present at the RBC Capital Markets 2017 Financial Institutions Conference
Feb 28, 2017 22:15 pm UTC| Business
CONWAY, Ark., Feb. 28, 2017 -- Home BancShares, Inc. (NASDAQ:HOMB), parent company of Centennial Bank, announced that it would participate in a panel discussion titled “Banking Unplugged” at the RBC Capital Markets 2017...
Dermira Announces Proposed Public Offering of Common Stock
Feb 28, 2017 22:14 pm UTC| Business
MENLO PARK, Calif., Feb. 28, 2017 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of...
LINN Energy Successfully Completes Financial Restructuring
Feb 28, 2017 22:13 pm UTC| Business
HOUSTON, Feb. 28, 2017 -- LINN Energy, Inc., the reorganized successor to LINN Energy, LLC, and its affiliated entities (the “Company” or “LINN”), today announced that it has emerged from Chapter 11 restructuring....
Delek US Holdings Announces Investor Conference Schedule
Feb 28, 2017 22:01 pm UTC| Business
BRENTWOOD, Tenn., Feb. 28, 2017 -- Delek US Holdings, Inc. (NYSE:DK) today announced management will attend the following upcoming investor conferences. Bank of America/Merrill Lynch Refining ConferenceDate: Thursday,...
Delek Logistics Partners, LP to Participate in the Barclays MLP Corporate Access Day
Feb 28, 2017 22:01 pm UTC| Business
BRENTWOOD, Tenn., Feb. 28, 2017 -- Delek Logistics Partners, LP (NYSE:DKL) today announced that Uzi Yemin, Chairman and CEO, Mark Smith, EVP and other members of Delek Logistics’ General Partner’s management will...
Feb 28, 2017 22:00 pm UTC| Business
RENO, Nev., Feb. 28, 2017 -- Ormat Technologies, Inc. (NYSE:ORA) today announced financial results for the fourth quarter and full year ended December 31, 2016. Financial Summary:($ millions, except per share amounts)4Q...
U.S. Appeals Court Allows Trump Administration to Enforce Medicaid Funding Ban on Planned Parenthood